ACQUIRED TYPE-II VONWILLEBRANDS DISEASE ASSOCIATED WITH ADRENAL-CORTICAL CARCINOMA

被引:45
作者
FACON, T
CARON, C
COURTIN, P
WURTZ, A
DEGHAYE, M
BAUTERS, F
MAZURIER, C
GOUDEMAND, J
机构
[1] CTR HOSP REG & UNIV LILLE,HEMATOL LAB B,F-59037 LILLE,FRANCE
[2] CTR HOSP REG & UNIV LILLE,ANAT PATHOL LAB C,F-59037 LILLE,FRANCE
[3] CTR HOSP REG & UNIV LILLE,CHIRURG CLIN A,F-59037 LILLE,FRANCE
[4] CTR HOSP REG & UNIV LILLE,SERV RADIOL,F-59037 LILLE,FRANCE
[5] CTR REG TRANSFUS SANGUINE,HEMOSTASE LAB,LILLE,FRANCE
关键词
D O I
10.1111/j.1365-2141.1992.tb04562.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A case of acquired von Willebrand's disease (AvWD) associated with an adrenal cortical carcinoma is reported. The circulating highest molecular weight multimers (HMWM) of von Willebrand factor (vWF) were decreased when assessed by SDS-agarose plasma electrophoresis, leading to the diagnosis of type II AvWD. No forms of inhibitor could be detected in the plasma of the patient. In contrast, indirect immunoperoxidase studies with a monoclonal antibody to vWF demonstrated an absorption of vWF into malignant cells. Infusion of a vWF-FVIII concentrate, containing significant amounts of HMWM of vWF, allowed surgical resection of the tumour. After the first infusion of the concentrate, the vWF-RCo recovery was found to be low (38%) compared to the vWF:Ag (75%) and FVIII:C (163%) recoveries. The resolution of all biological signs of vWD, including the abnormal multimeric pattern, in the post-operative period was prompt and permanent. Therefore, the absorption of the HMWM of vWF by carcinomatous cells appears to represent a likely pathophysiological mechanism responsible for the AvWD syndrome in this patient.
引用
收藏
页码:488 / 494
页数:7
相关论文
共 25 条
[1]  
ALLAIN JP, 1981, THROMB HAEMOSTASIS, V45, P285
[2]  
ALLAIN JP, 1984, SCAND J HAEMATOL S, V41, P123
[3]   DEMONSTRATION OF ABNORMAL FACTOR-VIII MULTIMERS IN ACQUIRED VON WILLEBRANDS DISEASE ASSOCIATED WITH A CIRCULATING INHIBITOR [J].
BALL, J ;
MALIA, RG ;
GREAVES, M ;
PRESTON, FE .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (01) :95-100
[4]   HEMORRHAGIC SYNDROME IN WALDENSTROMS MACROGLOBULINEMIA SECONDARY TO IMMUNOADSORPTION OF FACTOR-VIII - RECOVERY AFTER SPLENECTOMY [J].
BRODY, JI ;
HAIDAR, ME ;
ROSSMAN, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (08) :408-410
[5]  
BUDDE U, 1986, BLOOD, V68, P1213
[6]   CHARACTERIZATION OF VONWILLEBRAND-FACTOR IN FACTOR-VIII CONCENTRATES [J].
FRICKE, WA ;
YU, MYW .
AMERICAN JOURNAL OF HEMATOLOGY, 1989, 31 (01) :41-45
[7]  
FRICKE WA, 1985, BLOOD, V66, P562
[8]   ROLE OF TUMOR-CELL GLYCOPROTEINS IMMUNOLOGICALLY RELATED TO GLYCOPROTEINS-IB AND GLYCOPROTEIN-IIB/IIIA IN TUMOR-CELL PLATELET AND TUMOR-CELL MATRIX INTERACTIONS [J].
GROSSI, IM ;
HATFIELD, JS ;
FITZGERALD, LA ;
NEWCOMBE, M ;
TAYLOR, JD ;
HONN, KV .
FASEB JOURNAL, 1988, 2 (08) :2385-2395
[9]   ACQUIRED VONWILLEBRAND DISEASE - EVIDENCE FOR A QUANTITATIVE AND QUALITATIVE FACTOR-VIII DISORDER [J].
JOIST, JH ;
COWAN, JF ;
ZIMMERMAN, TS .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :988-991
[10]   COMPARISON OF THE INVITRO CHARACTERISTICS OF VONWILLEBRAND-FACTOR IN BRITISH AND COMMERCIAL FACTOR-VIII CONCENTRATES [J].
LAWRIE, AS ;
HARRISON, P ;
ARMSTRONG, AL ;
WILBOURN, BR ;
DALTON, RG ;
SAVIDGE, GF .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (01) :100-104